Save your place

Sign in to WhoBought

Please try again later.

Arcus Biosciences, Inc. (RCUS) institutional ownership

Latest close $29.73 Jul 23, 2026
Market cap$970M 52-week range SectorHealthcare
Funds holding · Q1 2026
200
reported RCUS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
113 buyers · 87 sellers

Arcus Biosciences, Inc. (RCUS) price and institutional activity

Dates

Q1 2026

$0 bought by 113 investors
Citadel Advisors LLCLogos Global Management LP +111 more
$0 sold by 87 investors
Point72 Asset Management, L.P.Toronto Dominion Bank +85 more
Bought Sold Totals per quarter; hover a bar for the names.

Arcus Biosciences, Inc. (RCUS) institutional activity · 200

Investor Type Est. change Change Δ Own Date
Point72 Asset Management, L.P. · Reduced
Change −3.2M Δ Own −96.1% Date Q1 2026
Point72 Asset Management, L.P. Reduced· Q1 2026 −3.2M −96.1% Q1 2026
Toronto Dominion Bank · Exited
Change −1.5M Δ Own −100.0% Date Q1 2026
Toronto Dominion Bank Exited· Q1 2026 −1.5M −100.0% Q1 2026
Citadel Advisors LLC Added· Q1 2026 +1.2M +1170.2% Q1 2026
Logos Global Management LP · New
Change +1.2M Date Q1 2026
Logos Global Management LP New· Q1 2026 +1.2M Q1 2026
Barclays PLC · Reduced
Change −1.0M Date Q1 2026
Barclays PLC Reduced· Q1 2026 −1.0M Q1 2026
Wellington Management Group LLP · Added
Change +905K Δ Own +17.5% Date Q1 2026
Wellington Management Group LLP Added· Q1 2026 +905K +17.5% Q1 2026
Vanguard · Added
Change +879K Date Q1 2026
Vanguard Added· Q1 2026 +879K Q1 2026
State Street · Added
Change +836K Date Q1 2026
State Street Added· Q1 2026 +836K Q1 2026
Balyasny Asset Management L.P. · Exited
Change −816K Δ Own −100.0% Date Q1 2026
Balyasny Asset Management L.P. Exited· Q1 2026 −816K −100.0% Q1 2026
Caption Management, LLC · Reduced
Change −752K Date Q1 2026
Caption Management, LLC Reduced· Q1 2026 −752K Q1 2026
First Turn Management, LLC · Exited
Change −565K Δ Own −100.0% Date Q1 2026
First Turn Management, LLC Exited· Q1 2026 −565K −100.0% Q1 2026
Jacobs Levy Equity Management, Inc · Reduced
Change −500K Date Q1 2026
Jacobs Levy Equity Management, Inc Reduced· Q1 2026 −500K Q1 2026
Invesco Ltd. · Added
Change +406K Δ Own +98.1% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +406K +98.1% Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +392K +1198.8% Q1 2026
Aberdeen Group PLC · Added
Change +385K Date Q1 2026
Aberdeen Group PLC Added· Q1 2026 +385K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 200

Famous investor activity in Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences, Inc. (RCUS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Jaen Juan C. · Officer 2 operations −$574K
Price $28.61–$29.40 Qty −20K Owned 822K ΔOwn −2.4% Trade date Jul 10, 2026 Filed date Jul 13, 2026
Jaen Juan C. Officer 2 operations $28.61–$29.40 −20K −$574K 822K −2.4% Jul 10, 2026 Jul 13, 2026
Jaen Juan C. · Officer Sell −$1.5M
Price $30.05 Qty −49K Owned 842K ΔOwn −5.4% Trade date Jul 9, 2026 Filed date Jul 13, 2026
Jaen Juan C. Officer Sell $30.05 −49K −$1.5M 842K −5.4% Jul 9, 2026 Jul 13, 2026
Jaen Juan C. · Officer Sell −$191K
Price $29.66 Qty −6K Owned 891K ΔOwn −0.7% Trade date Jun 24, 2026 Filed date Jun 24, 2026
Jaen Juan C. Officer Sell $29.66 −6K −$191K 891K −0.7% Jun 24, 2026 Jun 24, 2026
Jaen Juan C. · Officer 2 operations −$437K
Price $27.69–$28.06 Qty −16K Owned 897K ΔOwn −1.7% Trade date Jun 23, 2026 Filed date Jun 24, 2026
Jaen Juan C. Officer 2 operations $27.69–$28.06 −16K −$437K 897K −1.7% Jun 23, 2026 Jun 24, 2026
Jaen Juan C. · Officer Sell −$250K
Price $27.03 Qty −9K Owned 913K ΔOwn −1.0% Trade date Jun 22, 2026 Filed date Jun 24, 2026
Jaen Juan C. Officer Sell $27.03 −9K −$250K 913K −1.0% Jun 22, 2026 Jun 24, 2026
Lambert Nicole · Director 2 operations 23K
Owned 17K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Lambert Nicole Director 2 operations 23K 17K Jun 11, 2026 Jun 12, 2026
Machado Patrick · Director 2 operations 23K
Owned 17K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Machado Patrick Director 2 operations 23K 17K Jun 11, 2026 Jun 12, 2026
Kaneko Yasunori · Director 2 operations 23K
Owned 17K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Kaneko Yasunori Director 2 operations 23K 17K Jun 11, 2026 Jun 12, 2026
Tang Carolyn C. · Officer 2 operations $0
Price $2.57 Qty 0 Owned 0 Trade date Jun 11, 2026 Filed date Jun 12, 2026
Tang Carolyn C. Officer 2 operations $2.57 0 $0 0 Jun 11, 2026 Jun 12, 2026
Lacey David L. · Director 2 operations 23K
Owned 17K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Lacey David L. Director 2 operations 23K 17K Jun 11, 2026 Jun 12, 2026
Falberg Kathryn E. · Director 2 operations 23K
Owned 17K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Falberg Kathryn E. Director 2 operations 23K 17K Jun 11, 2026 Jun 12, 2026
Ribas Antoni · Director 2 operations 23K
Owned 17K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Ribas Antoni Director 2 operations 23K 17K Jun 11, 2026 Jun 12, 2026
Perlman Andrew J. · Director 2 operations 23K
Owned 17K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Perlman Andrew J. Director 2 operations 23K 17K Jun 11, 2026 Jun 12, 2026
Azoy Alexander · Officer Sell −$66K
Price $25.77 Qty −3K Owned 40K Trade date Jun 1, 2026 Filed date Jun 1, 2026
Azoy Alexander Officer Sell $25.77 −3K −$66K 40K Jun 1, 2026 Jun 1, 2026
Goeltz II Robert C. · CFO Sell −$199K
Price $25.63 Qty −8K Owned 84K Trade date May 11, 2026 Filed date May 12, 2026
Goeltz II Robert C. CFO Sell $25.63 −8K −$199K 84K May 11, 2026 May 12, 2026
15 of 60
15 of 60 Sign in to continue to older insider transactions.

Arcus Biosciences, Inc. (RCUS) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Gilead Sciences, Inc. 31.5M
% of shares outstanding 35.0% Filing date Jan 31, 2024
Gilead Sciences, Inc. 31.5M 35.0% Jan 31, 2024
BlackRock Inc. 10.0M
% of shares outstanding 13.4% Filing date Jan 23, 2024
BlackRock Inc. 10.0M 13.4% Jan 23, 2024
Blackrock, Inc. 9.7M
% of shares outstanding 10.6% Filing date Nov 8, 2024
Blackrock, Inc. 9.7M 10.6% Nov 8, 2024
Vanguard Group Inc 4.7M
% of shares outstanding 6.2% Filing date Feb 13, 2024
Vanguard Group Inc 4.7M 6.2% Feb 13, 2024
FMR LLC 4.5M
% of shares outstanding 4.9% Filing date Nov 12, 2024
FMR LLC 4.5M 4.9% Nov 12, 2024
Rosen Terry J 3.8M
% of shares outstanding 4.1% Filing date Dec 17, 2024
Rosen Terry J 3.8M 4.1% Dec 17, 2024
Pfm Health Sciences, LP 2.7M
% of shares outstanding 3.7% Filing date Feb 14, 2023
Pfm Health Sciences, LP 2.7M 3.7% Feb 14, 2023
State Street Corp 3.0M
% of shares outstanding 3.3% Filing date Oct 17, 2024
State Street Corp 3.0M 3.3% Oct 17, 2024
8 of 11

Arcus Biosciences, Inc. (RCUS) ownership FAQ

Who owns RCUS?

200 reporting institutions disclosed RCUS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.